All In Biotech

Drug Trial Radar · NCT05605509

RP-6306 in Patients With Advanced Cancer

A Phase II Study of RP-6306 in Patients With Advanced Cancer

Last checked: Nov 20, 2026Latest source record: Feb 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

28

Actual

Start

May 24, 2023

Primary completion

Nov 14, 2025

Study completion Feb 5, 2026

Sponsor

Lead sponsor
Canadian Cancer Trials GroupResearch network
Sponsor type
Research network
Collaborators
Repare Therapeutics
First posted
Nov 4, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being done to answer the following questions: * Is the new drug, RP-6306, safe to use, and what effects does it have on cancer when given with standard treatment? * If there are specific biomarkers, do patients have an improved response to treatment compared to those without the biomarker? This study is being done to find out if this approach is better or worse than the usual approach for this type of cancer. The usual approach is defined as care most people get for this type of cancer.

Conditions

  • Advanced Cancer

Interventions

  • RP-6306Drug

    Dose and schedule will be assigned at enrolment

  • GemcitabineDrug

    Dose and schedule will be assigned at enrolment

  • FOLFIRI ProtocolDrug

    Irinotecan Leucovorin FU

  • TrastuzumabDrug

    standard doses q3weekly

  • RP-3500Drug

    Dose and schedule will be assigned at enrolment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Response rate of RP-6306 in patients with selected cancers receiving standard agentTime frame: 2 years

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • BCCA - Kelowna

    Kelowna, British Columbia, Canada

  • BCCA - Vancouver

    Vancouver, British Columbia, Canada

  • Kingston Health Sciences Centre

    Kingston, Ontario, Canada

  • London Health Sciences Centre Research Inc.

    London, Ontario, Canada

  • Ottawa Hospital Research Institute

    Ottawa, Ontario, Canada

  • University Health Network

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.